India, Oct. 27 -- Doctors Without Borders/Médecins Sans Frontières and its research arm, Epicentre, said the first participant in the Tumaini Phase 2/3 clinical trial of vaccine candidates against Bundibugyo virus was vaccinated today in Bunia, Ituri province, as the Ebola disease outbreak continues in Democratic Republic of Congo.
Trial purpose and outbreak context
Doctors Without Borders/Médecins Sans Frontières said Democratic Republic of Congo is facing the largest Bundibugyo outbreak ever recorded and the second-largest Ebola disease outbreak to date. It said there is currently no approved vaccine against Bundibugyo, one of several viruses that cause Ebola disease.
Doctors Without Borders/Médecins Sans Frontières said the Tumaini tr...